Back to top
more

Cardinal Health (CAH)

(Delayed Data from NYSE)

$113.28 USD

113.28
1,294,834

+0.11 (0.10%)

Updated Sep 16, 2024 04:00 PM ET

After-Market: $113.27 -0.01 (-0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 36% (160 out of 251)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Nitish Marwah headshot

Top Ranked Momentum Stocks to Buy for November 25th

by Nitish Marwah

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, November 25th.

Is Cardinal Health (CAH) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Is (CAH) Outperforming Other Medical Stocks This Year?

Here's Why You Should Invest in Cooper Companies (COO) Stock

by Zacks Equity Research

Cooper Companies (COO) continues to benefit from solid CVI and CSI product portfolios.

Ecolab (ECL) Gets EPA Nod for Biofilm Disinfectant Virasept

by Zacks Equity Research

Ecolab's (ECL) Virasept has been developed to combat bacterial growth in hospitals.

Here's Why You Should Add DaVita (DVA) to Your Portfolio Now

by Zacks Equity Research

Investor confidence is high on DaVita (DVA) stock, thanks to solid prospects.

    Here's Why You Should Avoid Betting on Integer Holdings (ITGR)

    by Zacks Equity Research

    Stiff competition in the MedTech space and weak segmental and operational third-quarter 2020 performance weighs on Integer Holdings (ITGR).

    Top Ranked Momentum Stocks to Buy for November 20th

    by Zacks Equity Research

    Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, November 20th.

    NextGen (NXGN) Strengthens Portfolio of NextGen Solutions

    by Zacks Equity Research

    NextGen (NXGN) continues to boost its robust portfolio of NextGen solutions with the latest adoption of NextGen Enterprise by OSMC.

    Sanghamitra Saha headshot

    Rising P/E: An Ignored Trick to Pick 5 Winning Stocks

    by Sanghamitra Saha

    Want to try an out-of-the-box approach? Tap five stocks with increasing P/E ratios.

    Veeva Systems (VEEV) Boosts Portfolio of Cloud-Based Offerings

    by Zacks Equity Research

    Veeva Systems (VEEV) continues to boost its cloud-based offerings profile with the adoption of Vault PromoMats by Bristol Myers.

    Here's Why You Should Invest in Cardinal Health (CAH) Stock

    by Zacks Equity Research

    Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment, diversified product portfolio and strategic buyouts.

    LHC Group (LHCG) Forays into Oklahoma With New Hospice Buyout

    by Zacks Equity Research

    LHC Group (LHCG) buys Grace Hospice of Oklahoma to expand its hospice service to Tulsa and throughout the nation.

    Here's Why You Should Retain Stryker (SYK) Stock Right Now

    by Zacks Equity Research

    Stryker (SYK) continues to benefit from strength in its robotic-arm assisted surgery platform - Mako and broad product portfolio. However, pricing pressure raises concern.

    PerkinElmer's Non-Invasive Saliva-Based Testing Gets CE Mark

    by Zacks Equity Research

    PerkinElmer's (PKI) new saliva-based collection and asymptomatic test solution receives CE-IVD mark.

    Why Cardinal Health (CAH) is Such a Great Value Stock Pick Right Now

    by Zacks Equity Research

    Cardinal Health (CAH) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and is seeing solid earnings estimate revisions as well.

    Here's Why You Should Retain McKesson (MCK) Stock for Now

    by Zacks Equity Research

    McKesson (MCK) continues to benefit from multi-year strategic growth initiative and Distribution Solutions segment.

    CAH vs. ALGN: Which Stock Should Value Investors Buy Now?

    by Zacks Equity Research

    CAH vs. ALGN: Which Stock Is the Better Value Option?

    Has Cardinal Health (CAH) Outpaced Other Medical Stocks This Year?

    by Zacks Equity Research

    Is (CAH) Outperforming Other Medical Stocks This Year?

    Stock Market News for Nov 6, 2020

    by Zacks Equity Research

    U.S. stock markets closed sharply higher on Thursday as the wait for the U.S. Presidential election outcome continues.

    Cardinal Health (CAH) Q1 Earnings and Revenues Beat Estimates

    by Zacks Equity Research

    Cardinal Health's (CAH) fiscal first-quarter results reflect strong segmental performance.

    Cardinal Health (CAH) Q1 Earnings and Revenues Top Estimates

    by Zacks Equity Research

    Cardinal (CAH) delivered earnings and revenue surprises of 32.46% and 1.68%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

    Will Cigna (CI) Maintain Its Beat Streak in Q3 Earnings?

    by Zacks Equity Research

    Cigna's (CI) Q3 results are likely to reflect revenue growth owing to a strong fundamental performance. Earnings, however, might have been affected by steep medical costs from moderation in deferment of care related to the COVID-19 pandemic.

    Should You Buy Cardinal Health (CAH) Ahead of Earnings?

    by Zacks Equity Research

    Cardinal Health (CAH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

    Trina Mukherjee headshot

    Medical Products' Nov 5 Earnings Roster: BDX, ABC & More

    by Trina Mukherjee

    Medical Product companies have shown strength in the third quarter on the back of huge adoption of COVID-19 related healthcare-support products and services despite the impact of the ongoing pandemic.

    Cardinal Health (CAH) to Post Q1 Earnings: What's in Store?

    by Zacks Equity Research

    Cardinal Health's (CAH) fiscal first-quarter results are likely to reflect solid performance in Pharmaceutical segment.